Skip to main content

Advertisement

Log in

IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The mechanism of tumorigenesis associated with nicotinamide adenine dinucleotide phosphate (NADP+)-dependent isocitrate dehydrogenase 1 (IDH1) mutations in gliomas is not fully understood. Loss of catalytic activity leading to a decrease in α-ketoglutarate (αKG) and gain of novel catalytic activity leading to production of d-2-hydroxylglutarate (d-2-HG) are both found in IDH1-mutated glioma cells. Both the decrease of αKG and accumulation of d-2-HG inhibit the activity of multiple dioxygenases including prolyl hydroxylase domain-2 (PHD2), collagen prolyl-4-hydroxylase, histone demethylases, and the ten–eleven translocation (TET) family of 5-methylcytosine hydroxylases. Here we correlated the products of these dioxygenases after IDH1 gene mutations with tumorigenesis in human astroglioma samples. DNA sequencing was carried out for 253 astroglioma samples to identify IDH1 mutations. Immunohistochemistry analysis was employed to verify the levels of endostatin, dimethylated H3k79 (H3k79me2), and 5-hydroxymethylcytosine (5hmC) in these astroglioma samples. IDH1 mutations occurred frequently in low grades of astrocytoma. One case bearing both IDH1 and IDH2 mutations was identified. IDH1-mutated cases displayed more frontal lobe location and p53-positive immunostaining than wild-type cases. IDH1 mutations were associated with increased histone methylation and decreased 5hmC. By inhibiting endostatin expression, IDH1 mutations indirectly promoted angiogenesis in gliomas. All these changes were same in astroglioma at different malignancy grade. IDH1 mutations showed wide regulation of angiogenesis and genome-wide change of histone and DNA methylation, which were not suppressed as the malignancy level progressed, suggesting an early role of IDH1 mutations in astrocytoma tumorigenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812. doi:10.1126

    Article  PubMed  CAS  Google Scholar 

  2. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773. doi:10.1056/NEJMoa0808710

    Article  PubMed  CAS  Google Scholar 

  3. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine RL, Thompson CB (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:225–234. doi:10.1016/jccr201001020

    Article  PubMed  CAS  Google Scholar 

  4. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Seo SI, Lee JY, Yoo NJ, Lee SH (2009) Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 125:353–355. doi:10.1002/ijc.24379

    Article  PubMed  CAS  Google Scholar 

  5. Hartong DT, Dange M, McGee TL, Berson EL, Dryja TP, Colman RF (2008) Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat Genet 40:1230–1234. doi:10.1038/ng.223

    Article  PubMed  CAS  Google Scholar 

  6. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, Ding J, Lei Q, Guan KL, Xiong Y (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261–265. doi:10.1126/science.1170944

    Article  PubMed  CAS  Google Scholar 

  7. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739–744. doi:10.1038/nature08617

    Article  PubMed  CAS  Google Scholar 

  8. Rzem R, Veiga-da-Cunha M, Noël G, Goffette S, Nassogne MC, Tabarki B, Schöller C, Marquardt T, Vikkula M, Van Schaftingen E (2004) A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101:16849–16854. doi:10.1073/pnas.0404840101

    Article  PubMed  CAS  Google Scholar 

  9. Topçu M, Jobard F, Halliez S, Coskun T, Yalçinkayal C, Gerceker FO, Wanders RJ, Prud’homme JF, Lathrop M, Ozguc M, Fischer J (2004) L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13:2803–2811. doi:10.1093/hmg/ddh300

    Article  PubMed  Google Scholar 

  10. Aghili M, Zahedi F, Rafiee E (2009) Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol 91:233–236. doi:10.1007/s11060-008-9706-2

    Article  PubMed  Google Scholar 

  11. Annunen P, Helaakoski T, Myllyharju J, Veijola J, Pihlajaniemi T, Kivirikko KI (1997) Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer. The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II) beta2 tetramer. J Biol Chem 272:17342–17348. doi:10.1074/jbc.272.28.17342

    Article  PubMed  CAS  Google Scholar 

  12. Falnes PØ, Johansen RF, Seeberg E (2002) AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419:178–182. doi:10.1038/nature01048

    Article  PubMed  CAS  Google Scholar 

  13. Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J (2003) Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278:30772–30780. doi:10.1074/jbc.M304982200

    Article  PubMed  Google Scholar 

  14. Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J (2004) Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 279:9899–9904. doi:10.1074/jbc.M312254200

    PubMed  Google Scholar 

  15. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, Liu LX, Jiang WQ, Liu J, Zhang JY, Wang B, Frye S, Zhang Y, Xu YH, Lei QY, Guan KL, Zhao SM, Xiong Y (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30. doi:10.1016/j.ccr.2010.12.014

    Article  PubMed  CAS  Google Scholar 

  16. Kivirikko KI, Myllylä R, Pihlajaniemi T (1989) Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J 3:1609–1617. doi:10.1074/jbc.M312254200

    PubMed  CAS  Google Scholar 

  17. O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285. doi:S0092-8674(00)81848-6

    Article  PubMed  Google Scholar 

  18. Krane SM (2008) The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 35:703–710. doi:10.1007/s00726-008-0073-2

    Article  PubMed  CAS  Google Scholar 

  19. Klose RJ, Kallin EM, Zhang Y (2006) JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 7:715–727. doi:10.1038/nrg1945

    Article  PubMed  CAS  Google Scholar 

  20. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU, Xia X, Jesneck J, Bracken AP, Silverman LB, Kutok JL, Kung AL, Armstrong SA (2008) H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14:355–368. doi:10.1016/j.ccr.2008.10.001

    Article  PubMed  CAS  Google Scholar 

  21. Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9:465–476. doi:10.1038/nrg2341

    Article  PubMed  CAS  Google Scholar 

  22. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597–602. doi:10.1007/s00401-008-0455-2

    Article  PubMed  CAS  Google Scholar 

  23. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29:4482–4490

    Article  PubMed  CAS  Google Scholar 

  24. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297–310

    Article  PubMed  CAS  Google Scholar 

  25. Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, Yano T, Shibata M, Ohno K, Hirakawa K, Yamaguchi N (2002) Increased levels of tissue endostatin in human malignant gliomas. Clin Cancer Res 8:2933–2938 http://clincancerres.aacrjournals.org/content/8/9/2933.long

    Google Scholar 

  26. Sakurai T, Kudo M (2011) Signaling pathways governing tumor angiogenesis. Oncology 81:24–29. doi:10.1159/000333256

    Article  PubMed  CAS  Google Scholar 

  27. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES (2006) A bivalent chromatin structure marks key developemtal genes in embryonic stem cells. Cell 125:315–326. doi:10.1016/j.cell.2006.02.041

    Article  PubMed  CAS  Google Scholar 

  28. Zhu JK, Active DNA (2009) Demethylation mediated by DNA glucosylases. Annu Rev Genet 43:143–166. doi:10.1146/annurev-genet-102108-134205

    Article  PubMed  CAS  Google Scholar 

  29. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome intergrates intrinsic and environmental signals. Nat Genet suppl 33:245–254. http://dx.doi.org/10.1038/ng1089

  30. Ooi SK, Bestor TH (2008) The colorful history of active DNA demethylation. Cell 133:1145–1148. doi:10.1016/j.cell.2008.06.009

    Article  PubMed  CAS  Google Scholar 

  31. Bonasio R, Tu S, Reinberg D (2010) Molecular dignals of epigenetic states. Science 330:612–616. doi:10.1126/science.1191078

    Article  PubMed  CAS  Google Scholar 

  32. Feng J, Fan G (2009) The roles of DNA methylation in the central nervous system and neuropsychiatric disorders. Int Rev Neurobiol 89:67–84. doi:10.1016/S0074-7742(09)89004-1

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Professor Xue Xiong for critical suggestions on the manuscript. This work was support by Chinese National Science Foundation grants (30500189), Shanghai Nature Science Foundation Grants (12ZR1403200).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Liu.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Jiang, W., Liu, J. et al. IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma. J Neurooncol 109, 253–260 (2012). https://doi.org/10.1007/s11060-012-0914-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-012-0914-4

Keywords

Navigation